It all starts with what we call Q1
Q1 is a quantum leap in design of the humble syringe
Q-System Explained
Q1
Q1 | The Delivery Device
Bubbleject is a prefilled injection device designed to be formed, filled, and sealed in one sterile Blow-Fill-Seal process, making injectable medicines economic to produce, limitless to scale, and easy to use.
Q2
Q2 | Advanced BFS Manufacturing
Blow-Fill-Seal technology forms, fills, and seals containers in a single uninterrupted cycle, removing exposure and reducing contamination risk.
Q3
Q3 | Integrated Quality Control
High-speed planar inspection verifies fill level, seal integrity, and visual defects within seconds, automatically rejecting non-conforming units in a compact footprint.
Q4
Q4 | Connected Data & Traceability
Continuous monitoring and individual digital traceability support quality assurance, audit readiness, and global deployment.
16 CORE ADVANTAGES
Economics & Deployment
01
Lower Cost Per Dose
Fewer process steps and higher automation reduce operational overhead.
02
Scalable By Replication
Capacity increases by copying validated systems rather than constructing oversized facilities.
03
Compact Facility Footprint
Integration removes unnecessary buffers and staging areas, reducing infrastructure demands.
04
Reduced Labour Intensity
Continuous automated monitoring and digital traceability for every unit ensure quality, simplify audits, and all with greatly reduced labour intensity..
16 CORE ADVANTAGES
Healthcare System & Patient Benefit
05
Improved Access & Resilience
Local capacity strengthens continuity of supply for essential medicines.
06
Ready-to-use Prefilled Formats
Fewer preparation steps mean fewer dosing errors. Blow-Fill-Seal forms, fills, and seals each container in one continuous process, keeping the medicine enclosed and reducing contamination risk.
07
Emergency Rapid Deployment
Modular systems can be installed closer to demand when needed.
08
Simple Training & Administration
Prefilled, integrated devices are easier for healthcare workers to be trained and use quickly and safely.
16 CORE ADVANTAGES
Ecological & System Efficiency
09
Energy-Efficient Continuous Production
Steady-state manufacturing avoids repeated stop–start inefficiencies.
10
Lower Material Waste
Integrated production reduces packaging layers and process losses.
11
Shorter Supply Chains
Regional deployment reduces long-distance shipping and associated carbon impact.
12
Reduced Cold-Chain Burden
Localised production can reduce storage and transport intensity for certain products.
16 CORE ADVANTAGES
Manufacturing & Quality Control
13
Continuous Sterile Workflow
API flows directly into BFS injectors which integrate directly with quality control automation, removing open handling and process breaks.
14
Reduced Contamination Risk
Fewer manual interventions and fewer transfer points lower exposure risks.
15
System - Level Validation
The platform is designed and qualified as one coherent architecture, improving regulatory clarity.
16
High Repeatability & Consistency
Every unit follows the same controlled path, supporting predictable batch performance.
See You In Australia
